USS Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.88M	Buy	26,848 +624	+2%	+$212K	0.03%	256
2025 Q4	$10.4M	Sell	26,224 -142	-0.5%	-$62.8K	0.05%	215
2025 Q3	$12M	Hold	26,366	–	–	0.05%	194
2025 Q2	$8.59M	Hold	26,366	–	–	0.05%	234
2025 Q1	$7.12M	Hold	26,366	–	–	0.05%	254
2024 Q4	$6.21M	Sell	26,366 -6,505	-20%	-$1.71M	0.04%	332
2024 Q3	$9.04M	Sell	32,871 -3,976	-11%	-$1.04M	0.07%	266
2024 Q2	$8.96M	Buy	36,847 +1,433	+4%	+$226K	0.07%	226
2024 Q1	$5.29M	Buy	35,414 +3,712	+12%	+$619K	0.04%	370
2023 Q4	$6.07M	Sell	31,702 -2,529	-7%	-$431K	0.05%	312
2023 Q3	$6.06M	Buy	34,231 +4,206	+14%	+$802K	0.07%	307
2023 Q2	$5.71M	Hold	30,025	–	–	0.07%	320
2023 Q1	$6.01M	Sell	30,025 -1,209	-4%	-$254K	0.08%	285
2022 Q4	$7.42M	Sell	31,234 -45,569	-59%	-$9.72M	0.1%	225
2022 Q3	$15.4M	Sell	76,803 -363	-0.5%	-$69.2K	0.22%	96
2022 Q2	$11.3M	Sell	77,166 -2,796	-3%	-$397K	0.11%	189
2022 Q1	$13.1M	Buy	79,962 +4,222	+6%	+$643K	0.11%	199
2021 Q4	$12.9M	Hold	75,740	–	–	0.1%	205
2021 Q3	$14.3M	Buy	75,740 +18,882	+33%	+$3.54M	0.12%	177
2021 Q2	$9.63M	Buy	56,858 +49,900	+717%	+$7.31M	0.08%	168
2021 Q1	$983K	Hold	6,958	–	–	0.01%	511
2020 Q4	$905K	Hold	6,958	–	–	0.01%	509
2020 Q3	$1.01M	Hold	6,958	–	–	0.01%	470
2020 Q2	$1.03M	Buy	+6,958	New	+$938K	0.01%	459
2015 Q4	–	Sell	-276,572	Closed	-$22.2M	–	151
2015 Q3	$22.2M	Buy	+276,572	New	+$30.7M	0.39%	68